GEN Exclusives

More »

Wall Street BioBeat

More »

You are previewing premium content. Sign up to GENSelect to read full article.

Feb 1, 2014 (Vol. 34, No. 3)

Novel Drugs Challenge Anti-TNFs for RA Treatment

Highly Innovative Therapeutics Progressing Rapidly in Rheumatoid Arthritis Space

  • Drug developers addressing rheumatoid arthritis (RA) therapeutics are challenging well-established TNF inhibitors with new approaches that promise better efficacy and fewer side effects. Leading ...

For full access to this content and other high value GENSelect content & services, please sign in or register for FREE below. LEARN MORE about GENSelect.

Login to GENSelect

I forgot my password

Join GENSelect for FREE

Make username same as email

I agree to the terms of genengnews.com



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?